Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06332274
Title tislelizUMaB in canceR Patients With molEcuLar residuaL Disease (UMBRELLA)
Acronym UMBRELLA
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Gustave Roussy, Cancer Campus, Grand Paris
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.